<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Optimizerx Corp — News on 6ix</title>
<link>https://6ix.com/company/optimizerx-corp</link>
<description>Latest news and press releases for Optimizerx Corp on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 08 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/optimizerx-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835a6f978dffbe2df10bbd7.webp</url>
<title>Optimizerx Corp</title>
<link>https://6ix.com/company/optimizerx-corp</link>
</image>
<item>
<title>OptimizeRx Appoints Mary Varghese Presti to Board of Directors</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-appoints-mary-varghese-presti-to-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-appoints-mary-varghese-presti-to-board-of-directors</guid>
<pubDate>Wed, 08 Apr 2026 04:00:00 GMT</pubDate>
<description>Microsoft Health & Life Sciences COO brings expertise in scaling healthcare platforms, commercializing new technologies, and driving operational efficiency</description>
</item>
<item>
<title>OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-reports-strong-fourth-quarter-and-full-year-2025-financial-results-26</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-reports-strong-fourth-quarter-and-full-year-2025-financial-results-26</guid>
<pubDate>Thu, 05 Mar 2026 05:00:00 GMT</pubDate>
<description>- Q4 revenue of $32.2 million- Q4 gross profit increased 9% year-over-year to $24.1 million- Q4 net income and adjusted EBITDA hit records at $5.0 million and</description>
</item>
<item>
<title>UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/optimizerx-corp/news/update-optimizerx-reports-strong-fourth-quarter-and-full-year-2025-financial-results-15</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/update-optimizerx-reports-strong-fourth-quarter-and-full-year-2025-financial-results-15</guid>
<pubDate>Thu, 05 Mar 2026 05:00:00 GMT</pubDate>
<description>- Q4 revenue of $32.2 million- Q4 gross profit increased 9% year-over-year to $24.1 million- Q4 net income and adjusted EBITDA hit records at $5.0 million and</description>
</item>
<item>
<title>OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-sets-fourth-quarter-full-130000529</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-sets-fourth-quarter-full-130000529</guid>
<pubDate>Thu, 05 Feb 2026 13:00:00 GMT</pubDate>
<description>WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, will hold a conference call on Thursday, March 5, 2026, at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter period ended December 31, 2025. The financial results will be issued in a press release prior to the call. OptimizeRx manage</description>
</item>
<item>
<title>OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-experian-collaborate-improve-privacy-130000638</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-experian-collaborate-improve-privacy-130000638</guid>
<pubDate>Wed, 07 Jan 2026 13:00:00 GMT</pubDate>
<description>Life science marketers will be able to better measure the exposed audiences for a more complete, accurate, and transparent view of campaign engagement and effectivenessWALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life science companies reach and engage healthcare professionals (HCPs) and patients, today announced at CES 2026 a data collaboration with Experian, a leading global data</description>
</item>
<item>
<title>OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-continues-expansion-company-point-093000676</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-continues-expansion-company-point-093000676</guid>
<pubDate>Wed, 17 Dec 2025 09:30:00 GMT</pubDate>
<description>Strategic Partnerships Add Exclusivity in Leading EHR, e-Prescription, and Technology Companies, Increasing NPI Reach by 37%WALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced four new partner agreements that meaningfully expand the Company’s in-workflow point-of-care (POC) network, fort</description>
</item>
<item>
<title>OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-reports-third-quarter-2025-210100679</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-reports-third-quarter-2025-210100679</guid>
<pubDate>Thu, 06 Nov 2025 21:01:00 GMT</pubDate>
<description>- Q3 revenue of $26.1 million, increased 22% year-over-year- Q3 gross profit increased 30% year-over-year to $17.5 million- Increases full year 2025 guidance to a revenue range between $105 million and $109 million and adjusted EBITDA range between $16 million and $19 million- Introduces 2026 guidance with a revenue range between $118 million and $124 million and adjusted EBITDA range between $19 million and $22 million- Paid off an incremental $2 million in principal from term loan subsequent t</description>
</item>
<item>
<title>OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-sets-third-quarter-2025-conference-call-for-november-6-2025-at-430-pm-et</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-sets-third-quarter-2025-conference-call-for-november-6-2025-at-430-pm-et</guid>
<pubDate>Mon, 20 Oct 2025 04:00:00 GMT</pubDate>
<description>WALTHAM, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions</description>
</item>
<item>
<title>OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-participate-9th-annual-lake-113000670</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-participate-9th-annual-lake-113000670</guid>
<pubDate>Wed, 10 Sep 2025 11:30:00 GMT</pubDate>
<description>WALTHAM, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference taking place Thursday, September 11, 2025, in New York, NY. To request a meeting or for more details about the Conference, please reach</description>
</item>
<item>
<title>OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-partners-lamar-advertising-reach-200500714</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-partners-lamar-advertising-reach-200500714</guid>
<pubDate>Tue, 09 Sep 2025 20:05:00 GMT</pubDate>
<description>Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar’s Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing WALTHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- OptimizeRx (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, and Lamar Advertising Company (Nasdaq: LAMR), one of the largest out-of-home (O</description>
</item>
<item>
<title>OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-corporation-announces-leadership-team-113000908</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-corporation-announces-leadership-team-113000908</guid>
<pubDate>Tue, 19 Aug 2025 11:30:00 GMT</pubDate>
<description>WALTHAM, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced organizational updates and leadership advancements designed to accelerate the Company’s Rule of 40 strategy—balancing sustained growth with increased profitability. These changes reflect the strength of the Company’s leadership bench an</description>
</item>
<item>
<title>OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-reports-second-quarter-2025-200100531</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-reports-second-quarter-2025-200100531</guid>
<pubDate>Thu, 07 Aug 2025 20:01:00 GMT</pubDate>
<description>Q2 revenue of $29.2 million, increased 55% year-over-yearQ2 gross profit increased 59% year-over-year to $18.6 millionPaid down $4.5 million of principal on outstanding term loan during Q2Increased full year 2025 guidance to a revenue range between $104 million and $108 million and adjusted EBITDA range between $14.5 million and $17.5 million WALTHAM, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions he</description>
</item>
<item>
<title>Paynela Appoints Healthcare Technology Veteran William Febbo to Board of Directors</title>
<link>https://6ix.com/company/optimizerx-corp/news/paynela-appoints-healthcare-technology-veteran-william-febbo-to-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/paynela-appoints-healthcare-technology-veteran-william-febbo-to-board-of-directors</guid>
<pubDate>Wed, 30 Jul 2025 04:00:00 GMT</pubDate>
<description>Former OptimizeRX CEO Brings Extensive Digital Health and Pharmaceutical Patient Assistance Expertise to AI-Driven Healthcare Financing Company NEW</description>
</item>
<item>
<title>OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-sets-second-quarter-2025-113000525</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-sets-second-quarter-2025-113000525</guid>
<pubDate>Thu, 17 Jul 2025 11:30:00 GMT</pubDate>
<description>WALTHAM, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, will hold a conference call on Thursday, August 7, 2025, at 4:30 p.m. Eastern Time to discuss its results for the second quarter period ended June 30, 2025. The financial results will be issued in a press release prior to the call. OptimizeRx managemen</description>
</item>
<item>
<title>OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-corporation-appoints-ceo-steve-113000231</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-corporation-appoints-ceo-steve-113000231</guid>
<pubDate>Tue, 24 Jun 2025 11:30:00 GMT</pubDate>
<description>WALTHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced the appointment of Steve Silvestro, currently serving as the Company’s Chief Executive Officer, to its Board of Directors, effective as of June 20, 2025. Mr. Silvestro joined the Company in 2019 and has been the Company’s CEO since Marc</description>
</item>
<item>
<title>Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions</title>
<link>https://6ix.com/company/optimizerx-corp/news/simulmedia-and-optimizerx-announce-partnership-from-the-cannes-lions</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/simulmedia-and-optimizerx-announce-partnership-from-the-cannes-lions</guid>
<pubDate>Wed, 18 Jun 2025 04:00:00 GMT</pubDate>
<description>Strategic Collaboration Brings Precision Micro-Neighborhood® Targeting Healthcare Consumer Audiences to Linear and Connected TV CANNES, France--(BUSINESS</description>
</item>
<item>
<title>OptimizeRx to Participate in Upcoming Investor Conferences</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-participate-upcoming-investor-conferences-113000764</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-participate-upcoming-investor-conferences-113000764</guid>
<pubDate>Fri, 16 May 2025 11:30:00 GMT</pubDate>
<description>WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences: B. Riley Securities 25th Annual Investor Conference, Marina del Rey, May 21 – 22, 2025Stifel 2025 Boston Cross Sector 1x1 Conference, Boston, June 3 – 4, 20</description>
</item>
<item>
<title>OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-reports-first-quarter-2025-200500704</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-reports-first-quarter-2025-200500704</guid>
<pubDate>Mon, 12 May 2025 20:05:00 GMT</pubDate>
<description>Q1 revenue of $21.9 million, increasing 11% year-over-yearQ1 gross profit increased 9% year-over-year to $13.3 millionIncreases full year 2025 guidance to a revenue range between $101 million and $106 million and adjusted EBITDA range between $13 million and $15 million WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HC</description>
</item>
<item>
<title>OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-releases-2025-environmental-social-200500595</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-releases-2025-environmental-social-200500595</guid>
<pubDate>Thu, 01 May 2025 20:05:00 GMT</pubDate>
<description>WALTHAM, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, has published its Environmental, Social and Governance (ESG) report for 2025. As a company focused on optimizing meaningful engagement opportunities at critical junctures of the healthcare journey, we remain dedicated to aligning our mission with our re</description>
</item>
<item>
<title>OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET</title>
<link>https://6ix.com/company/optimizerx-corp/news/optimizerx-sets-first-quarter-2025-113000780</link>
<guid isPermaLink="true">https://6ix.com/company/optimizerx-corp/news/optimizerx-sets-first-quarter-2025-113000780</guid>
<pubDate>Wed, 23 Apr 2025 11:30:00 GMT</pubDate>
<description>WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Monday, May 12, 2025, at 4:30 p.m. Eastern Time to discuss its results for the first quarter period ended March 31, 2025. The financial results will be issued in a press release prior to the call. OptimizeRx management wi</description>
</item>
</channel>
</rss>